Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
6 products were successfully identified as well-known brand products in Shandong in 2022
On December 23, the Shandong provincial brand building promotion society issued the notice about the disclosure of the identification result of a well-known brand (product service) in Shandong in 2022, and five products of Qidu Pharma and 1 product of Prosision Pharma were identified as well-known brand products in Shandong in 2022.
Qidu Pharma, once again among the Top 100 Enterprises in Chinese pharmaceutical industries
On December 17-19, the 39th Annual M
Major Events of Qidu Pharma in 2022
1. Diyixin® - Levofloxacin Hydrochloride and Sodium Chloride Injection researched and developed independently by Qidu Pharma
The annual summary recognition conference of the Qidu Pharmaceutical Group in 2022
On January 6, tQidu Pharmaceutical Group convened the 2022 annual summary recognition conference. Chairman Jiaqing Zheng chaired the meeting and made important speech, director of the Group Management Committee Jianli Zhang made the work report, and Secretary of the board and director of corp
Recently, the Department of industry and informatics of Shandong Province issued a list of pilot demonstration projects on the integration and development of new generation information technology and manufacturing industry in 2022, and the smart storage logistics platform project based on the pharmaceutical industry declared by Zidu pharmaceutical industry was evaluated on the typical application field of industrial Internet of Shandong Province. The project scenarios include fully automatic stereo warehouse construction, intelligent storage management system construction, logistics transport
Breaking news: GMP guideline for cell therapy products issued
On October 31, 2022, the SFDA food and drug review and inspection center officially issued the guidance for the quality management of the manufacture of cell therapy products (Trial). The full text of the guideline covers thirteen chapters covering basic principles of GMP management of cell therapy products, personnel, plants, facilities and equipment, donor screening and donor materials, materials and products, production management, qual
On November 1, the 10th member congress & 10th time Council of China Society of chemical and pharmaceutical industry was held in Beijing in an online manner. Jian Zhou, vice director of consumer products industry division, Ministry of industry and Informatics, Party Secretary of Chinese Industrial Economic Federation Xiong Meng, and Haidong Wu, executive director of Chinese Pharmaceutical Enterprise Management Association, attended and
Recently, the 2022 "Quality Pharmaceuticals" construction brand compliance activity sponsored by Shandong Provincial Association of pharmaceutical industry was satisfactorily ended under the guidance of Shandong Provincial Department of industry and informatics and Shandong provincial drug administration. Qidu pharmaceutical industry Yixin ®- Levofloxacin sodium chloride injection / levofloxacin tablets and Jiacong ®- Pediatric compound amino acid injection (19AA-I), yongpoly tech polymer pre potting syringe combination were obtained to evaluate the "Quality Pharmaceuticals" construction of
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.